Trends in utilization of hypofractionated whole breast irradiation (HF-WBI) in triple negative breast cancer (TNBC): a national cancer database (NCDB) analysis

被引：0
|
作者：
Stephanie R. Rice
Steven J. Feigenberg
Muhammad Hamza
Jason K. Molitoris
Søren M. Bentzen
Katherine H. R. Tkaczuk
Paula M. Rosenblatt
Emily C. Bellavance
Elizabeth M. Nichols
机构：
[1] University of Maryland School of Medicine,Department of Radiation Oncology
[2] University of Pennsylvania,Department of Radiation Oncology
[3] University of Maryland School of Medicine,Department of Epidemiology & Public Health, Greenebaum Cancer Center
[4] University of Maryland School of Medicine,Division of Hematology/Oncology, Department of Medicine
[5] University of Maryland School of Medicine,Department of Surgery
来源：
Breast Cancer Research and Treatment | 2019年 / 175卷
关键词：
Triple negative; Hypofractionated; Early stage; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：473 / 478
页数：5
相关论文
共 50 条
  • [31] Neoadjuvant systemic therapy in geriatric breast cancer patients: a National Cancer Database (NCDB) analysis
    Lauren Brown
    Samer A. Naffouje
    Christine Sam
    Christine Laronga
    M. Catherine Lee
    Breast Cancer Research and Treatment, 2022, 196 : 441 - 451
  • [32] Outcomes with External Beam Partial Breast Irradiation and Concurrent Chemotherapy (PBICC) Compared to Whole Breast Irradiation and Sequential Chemotherapy (WBISC) in Triple Negative Breast Cancer (TNBC) Patients
    DeSouza-Lawrence, L.
    Frassica, D.
    Asrari, F.
    Myers, L.
    Stearns, V.
    Wolff, A.
    Zellars, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S244 - S244
  • [33] The Role of Immunotherapy in Triple-Negative Breast Cancer (TNBC)
    Michaels, Elena
    Chen, Nan
    Nanda, Rita
    CLINICAL BREAST CANCER, 2024, 24 (04) : 263 - 270
  • [34] Current usage of pembrolizumab in triple negative breast cancer (TNBC)
    O'Rourke, Harriet
    Hart, Christopher
    De Boer, Richard H.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2024, 24 (05) : 253 - 261
  • [35] Histologic heterogeneity of triple negative breast cancer: a National Cancer Center Database study
    Mills, M.
    Yang, G.
    Oliver, D.
    Liveringhouse, C.
    Ahmed, K.
    Orman, A.
    Laronga, C.
    Diaz, R.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S80 - S81
  • [36] The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC)
    Shavira Narrandes
    Shujun Huang
    Leigh Murphy
    Wayne Xu
    BMC Cancer, 18
  • [37] The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC)
    Narrandes, Shavira
    Huang, Shujun
    Murphy, Leigh
    Xu, Wayne
    BMC CANCER, 2018, 18
  • [38] Phosphoproteomic portraits of triple-negative breast cancer (TNBC)
    Quintela-Fandino, Miguel
    Zagorac, Ivana
    Lopez-Acosta, Jose Francisco
    Gomez, Gonzalo
    Pisano, David G.
    Munoz, Javier
    Manso, Luis
    Alonso, Soledad
    Penning, Renske
    Altelaar, Maarten
    Heck, Albert J. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [39] Characterizing the role of Filopodia in Triple Negative Breast Cancer (TNBC).
    Lanns, D.
    Dalton, J.
    Galli, L. M.
    Burrus, L. W.
    MOLECULAR BIOLOGY OF THE CELL, 2018, 29 (26)
  • [40] THE ROLE OF IMMUNOTHERAPY IN THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER (TNBC)
    Rugo, Hope S.
    BREAST, 2017, 36 : S29 - S30
12345